Long-Term Clinical and Immunological Effects of Repeated Mesenchymal Stem Cell Injections in Patients With Progressive Forms of Multiple Sclerosis
Background: Mesenchymal stem cells (MSC) were shown to possess immunomodulatory and neurotrophic effects. Our previous trials, have shown that intrathecal (IT) and intravenous (IV) administration of MSCs were safe and provided indications of beneficial clinical effects.Methods: This is an open prosp...
Main Authors: | Panayiota Petrou, Ibrahim Kassis, Ariel Ginzberg, Michel Halimi, Nour Yaghmour, Oded Abramsky, Dimitrios Karussis |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-05-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2021.639315/full |
Similar Items
-
A phase II clinical trial with repeated intrathecal injections of autologous mesenchymal stem cells in patients with amyotrophic lateral sclerosis
by: Panayiota Petrou, et al.
Published: (2021-10-01) -
Mesenchymal stem cells in systemic sclerosis therapy
by: Daniel Witold Dudek, et al.
Published: (2020-10-01) -
Mesenchymal stem cell therapy: A review of clinical trials for multiple sclerosis
by: Asma Alanazi, et al.
Published: (2022-12-01) -
Stem Cell Therapies for Progressive Multiple Sclerosis
by: Jayden A. Smith, et al.
Published: (2021-07-01) -
MESENCHYMAL STEM CELLS AS A THERAPEUTIC STRATEGY FOR MULTIPLE SCLEROSIS: ISSUES AND PERSPECTIVES
by: M. M. Zafranskaya, et al.
Published: (2017-01-01)